REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Neurocor S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Neurocor S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neurocor S.A. is an enterprise in Ecuador, with the main office in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on May 12, 2011. Neurocor S.A. currently employs 9 (2023) people. The latest financial highlights indicate a net sales revenue increase of 36.16% in 2023. Over the same period, its total assets grew by 17.21%. The enterprise’s net profit margin decreased by 10.74% in 2023.

Headquarters
Av. Rodolfo Baquerizo Nazur Mz 12-27, C.C.Gran Albocentro Bldg. , Floor 6
Guayaquil; Guayas;

Contact Details: Purchase the Neurocor S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Neurocor S.A. report to view the information.
Outstanding Shares:
Purchase the Neurocor S.A. report to view the information.
Registered Capital:
Purchase the Neurocor S.A. report to view the information.
Incorporation Date:
May 12, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Neurocor S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
36.16%▲
Total operating revenue
36.16%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-30.37%▼
Total assets
17.21%▲
Total equity
31.31%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-10.74%▼
Return on Equity (ROE)
-12.12%▼
Debt to Equity Ratio
-0.12%▼
Quick Ratio
-0.26%▼
Cash Ratio
-0.2%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo